Search for: [Abstract = "f ascites. It was not shown a correlation between serum sHLA\-G and CA\-125 serum. It was shown the significantly higher levels of sHLA\-G prior to surgery as compared to the concentration after the treatment. ROC curve showed the diagnostic usefulness of measuring sHLA\-G in serum of patients with endometriosis and ovarian cancer, especially advanced. The lowest concentration of sHLA\-G was observed in the control group of women in the menopausal stage, while the highest in deep endometriosis in the secretory phase and in ovarian cancer. The conclusions of the study\: 1. The protein concentration of sHLA\-G in serum was higher in patients with ovarian cancer compared to the reference group and depend on the clinical stage of cancer according to FIGO classification and the degree of histological differentiation\; 2. The protein concentration of sHLA\-G in serum was higher in patients with endometriosis compared to the reference group and depend on the clinical stage of disease according to the classification rAFS. Such behavior of the sHLA\-G in ovarian cancer and endometriosis may suggest that the development of these diseases with different clinical characteristics, is essential to the state of the immune system, which is one of the markers of sHLA\-G protein\; 3. It was observed decreased concentration of sHLA\-G in serum after cytoreductive surgery for ovarian cancer, which may"]

Number of results: 1